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Abstract 
 
A 25-year-old female presented to a university neurology clinic with a one-month history of 
progressive ataxia, downbeat nystagmus and spastic tetraparesis. Personal history revealed 
polyarthralgias and weight loss. Family history was negative. After thorough history, 
laboratory, neurophysiological and MRI investigations, a diagnosis of cerebellar ataxia due to 
coeliac disease was made. The patient was treated with strict gluten-free diet and intravenous 
immunoglobulins. Although there are many controversies about neurological manifestations 
of coeliac disease, this case pointed to strong association between these two disorders. The 
findings of elevated protein content in the cerebrospinal fluid with positive oligoclonal bands 
suggested an immune-mediated process, further supported by positive anti-endomysium 
antibodies and anti-transglutaminase antibodies in the cerebrospinal fluid. 
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We describe a case of ataxia, spastic tetraparesis and cognitive decline due to coeliac disease. 
 
Case Report 
A 25-year-old woman was referred to our department because of ataxia. Her personal history 
revealed polyarthralgia three years before because of which she was evaluated at internal 
medicine department; immunological tests were negative and she was diagnosed with reactive 
arthritis. Therapy with low dose corticosteroids resulted in complete recovery. After that, she 
developed postural tremor in her upper extremities, was examined by local neurologist and 
prescribed propranolol for presumed essential tremor. Two years later, she was hospitalized at 
Department of Internal Medicine for recurrent polyarthralgia. Ureaplasma urealyticum was 
isolated from cervical smear; therapy with doxycycline led to full recovery. 
One month before admission to our department, she was hospitalized again at local 
Department of Internal Medicine for 15 kg weight loss and polyarthralgia especially affecting 
her hands. At the same time, she started developing walking difficulties, oscillopsia and 
occasional diplopia. Her complaints were initially thought to be consequential to depression; 
therefore, she was transferred to Department of Psychiatry, where therapy with sertraline and 
sulpiride was initiated. As she did not recover, a neurologist was consulted and the patient 
was transferred to our department.  
On admission, neurological examination revealed fully alert patient, her speech showed 
scanning dysarthria. She had downbeat nystagmus in all directions of gaze, more pronounced 
in full lateral gaze (Video 1), spastic tetraparesis, muscle strength was 3/5 on the right hand, 
4/5 on the right hand, 2/5 on the right leg and 3/5 on the left leg, decreased reflexes (1+) and 
positive Babinski bilaterally. She had severe dysmetria and intentional tremor on all four 
extremities, and she could neither walk nor sit on her own. Cognitive examination showed 
Minimental state examination 29/30, ACE-R 94/100, mainly due to the visuospatial 
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component of the test, which could be explained by motor and coordination problems. Family 
history for ataxia was negative. 
Laboratory results showed elevated erythrocyte sedimentation rate (40 mm/h), and normal 
complete blood count, electrolytes, liver and kidney function tests, and C-reactive protein. 
She had normal T3, T4 and TSH levels, but elevated anti-TPO antibodies (>2000 IU/mL). 
She also had normal values of Fe, UIBC, TIBC, serum protein electrophoresis, IgA, IgG and 
IgM, ACE, coagulation tests, vitamin B12, folic acid, antiganglioside antibodies, tumour 
markers, anti-Hu, -Yo and -Ri antibodies, hepatitis B, C, HIV, VDRL, TPHA, and Borrelia 
burgdorferi serology. Genetic tests for SCA 1,2,3,6 and Friedrich ataxia were negative. 
Immunologic tests (ANA; dsDNA, ENA, anticardiolipin antibodies, ANCA, C3, C4, CH50) 
were negative. Brain MRI showed normal results. Cerebrospinal fluid (CSF) analysis revealed 
2 small lymphocytes/mm
3
, elevated proteins 0.93 g/L (n.v. <0.37 g/L), and positive 
oligoclonal bands. Electroneurography showed signs of mild sensory polyneuropathy. 
Because of weight loss and polyarthralgias, we performed upper endoscopy with distal 
duodenal biopsy. Histopathology showed villous atrophy, crypt hyperplasia, increased 
mononuclear infiltration of the lamina propria and an increased number of intraepithelial 
lymphocytes (25 per 100 epithelial cells). PAS staining was negative. We then performed 
serum IgA anti-endomysium antibodies (EMA), which were negative, and serum IgA anti-
transglutaminase antibodies (tTG), which were positive (68 RU/mL), with normal levels of 
serum IgA. We also performed additional CSF analysis for these antibodies and both were 
positive (EMA positive titre and tTG 84 RU/mL). HLA genotyping revealed the HLA DQ 2 
allele.  
The diagnosis of cerebellar ataxia due to coeliac disease (CD) was made. The patient was 
treated with 50 g of intravenous immunoglobulins with modest recovery and she was 
transferred to stationary rehabilitation on strict gluten free diet. On follow-up at 3 and 6 
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months, she was stable, with modest improvement of motor strength but persistent ataxia. 
Repeat EMA and tTG antibodies were negative, and gastrodudenoscopy was normal, 
confirming the patient was adherent to the diet.  
 
Discussion 
In this case, the patient presented with severe cerebellar syndrome. The most prominent 
neurological feature was downbeat nystagmus (DBN) (Video 1). DBN is often the result of a 
bilateral lesion of the flocculus or paraflocculus, or is caused by a lesion at the bottom of the 
4
th
 ventricle
1,2
.
 
 It is estimated that DBN is either a drug-induced dysfunction or is associated 
with structural lesion (25% of cases with craniocervical junction anomalies, e.g., Chiari 
malformation and 20% with cerebellar degeneration); however, the etiology remains 
unknown in about 50% of cases
2
. Our patient also had signs of pyramidal tract involvement 
and brain MRI was completely normal indicating a more diffuse pathological process. 
Another important fact was the history of polyarthralgia and weight loss, which indicated 
systemic illness. That is why upper endoscopy with distal duodenal biopsy was performed to 
yield histopathologic findings consistent with CD. These findings were confirmed by positive 
serum IgA tTG. The final diagnosis was based on positive EMA and tTG in the CSF.  
Coeliac diseases is a chronic immune mediated disorder that primarily
 
affects the 
gastrointestinal tract. Many patients, especially adults, may
 
be asymptomatic or have only 
extraintestinal symptoms at the onset,
 
without any of the classical coeliac symptoms
3
. The 
best described neurological complications of CD are ataxia, peripheral neuropathy and 
epilepsy, and more controversial ones include myopathy, autonomic
 
neuropathy, white matter 
lesions, headache, cognitive impairment,
 
multiple system atrophy, dystonia and childhood 
stroke
4
. There is strongest evidence for the association of ataxia and CD. The only 
pathological studies performed in patients with CD and ataxia showed that there was 
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lymphocytic infiltration of the cerebellum, damage to the posterior columns of the spinal 
cord, and sparse infiltration of the peripheral nerves
5
. These findings support the hypothesis 
that neurological manifestations of CD are immune mediated. Evidence suggests that there 
might be antibody cross-reactivity between antigenic epitopes on Purkinje cells and gluten 
proteins. Serum from patients with gluten ataxia and from patients with CD without 
neurological symptoms showed cross-reactivity with epitopes on Purkinje cells of both human 
and rat cerebellum
6
. Other studies have shown no association between CD and ataxia
7
. 
However, CD was found in 36% of patients with idiopathic cerebellar ataxia with 
extracerebellar presentation (autonomic instability, parkinsonism, or pyramidal dysfunction in 
varying combinations)
8
. Similarly, our patient had cerebellar symptomatology with pyramidal 
tract involvement. All of these studies had many limitations
4
, and although there are no 
prospective studies, evidence weighs in support of causal relationship between ataxia and CD. 
However, one prospective study indicated that neuropathy, usually subclinical, may 
accompany CD and antibody titres did not seem to correlate with neurological symptoms 
and/or signs or diet
9
. It is also worthy mentioning that subclinical neurological abnormalities 
associated with CD are found in 11% of children with CD, meaning that these patients should 
be carefully monitored for neurologial compliacations
10
. Some patients with ataxia who have 
normal duodenal biopsy and positive antigliadin antibodies may also have HLA haplotypes 
that are associated with CD
11
, indicating a wide spectrum of clinical manifestations of gluten 
sensitivity and suggesting the possibility that such patients might develop CD at some time 
point
12
. 
Only few studies investigated the role of antigliadin, tTg and EMA in the CSF. In one study, 
the authors analyzed the presence of IgA and IgG tTG in 129 samples and found positive 
titres in 27 and 63 CSF samples, respectively. Unfortunately, there are no clinical data on the 
patients and on the possible presence of CD in these patients
13
. Another study showed 
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negative CSF antigliadin antibodies and EMA in all study patients with ataxia and CD
11
. The 
role of tTG and EMA CSF antibodies remains to be elucidated.   
Differential diagnosis of sporadic, adult onset ataxias is broad, especially if neurological 
findings such as pyramidal or sensory tract involvement are present. Autosomal dominant 
spinocerebellar ataxias may have diverse associated neurological features including 
retinopathy, optic atrophy, extrapyramidal or pyramidal signs, peripheral neuropathy, 
cognitive impairment, or epilepsy, but in most instances family history is positive, although it 
may not be clearly visible
14
. Autosomal recessive ataxias are generally associated with 
peripheral sensorimotor neuropathy, most notably with loss of proprioception and vibration 
sense, and tend to have involvement outside the nervous system
15
. Although most of recessive 
ataxias have their onset in childhood, late-onset Freidreich ataxia (FA) (>25 years of age) can 
present with gait and limb ataxia, dysarthria, loss of vibration sense, abnormal eye 
movements, limb spasticity and retained reflexes
16
. The patient presented had all these 
features, but genetic tests for FA and for most frequent dominant ataxias were negative. 
When the symptoms are not restricted to the central nervous system, systemic diseases should 
be considered. In this case study, associated polyarthralgia and weight loss suggested neuro-
Whipple’s disease. Neuro-Whipple’s disease can present with gastrointestinal or 
rheumatologic
 
features, or as a primary central nervous system infection, but neurological
 
manifestations do not distinguish primary from secondary form of the disease, emphasizing 
that brain MRI can be normal and
 
any abnormalities are non-specific
17
. The diagnosis is made 
by duodenal, lymph node or brain biopsy, polymerase chain reaction (PCR) analysis and CSF 
analysis; MRI is crucial during follow-up, and treatment consists of prolonged antibiotic 
therapy with drugs able to cross the blood-brain barrier
18
. In our patient, Whipple's disease 
was excluded by negative duodenal biopsy. 
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Ataxia associated with CD can have almost identical presentation as neuro-Whipple's disease, 
as discussed in more detail in previous chapter. Hypothyroidism can also present with ataxia, 
however, these patients usually do not have weight loss. Patients with neurological 
manifestations and positive anti-TPO antibodies are often diagnosed with Hashimoto 
encephalopathy, but this disease almost never presents with ataxia
19
. On the other hand, 
patients with CD often have associated autoimmune disorders, the pathogenesis of which is 
not known, but these conditions share similar HLA haplotypes, so screening of high risk 
patients for CD, such as those with autoimmune diseases, is a reasonable strategy given the 
increased prevalence
20
. 
Currently, the only treatment for CD is adherence to strict gluten-free diet
21
. However, 
neurological manifestations, especially neuropathy and ataxia, seem to be resistant to strict 
gluten-free diet
11
. Recently, there is evidence for the effect of intravenous immunoglobulins 
in ataxia and peripheral neuropathy associated with CD
22,23
. Maintenance IVIG treatment may 
be needed for long-term management of these disorders
22,23
. The fact that neurological 
symptoms improve or are even reversible in response to IVIG suggests an immune-mediated 
process that may be occurring independently of gluten exposure
23
. The effect of IVIG 
treatment in our patient was modest; there was significant improvement of nystagmus and 
muscle strength, but only modest in ataxia. Although we are in need of prospective 
randomized trials in the management of neurological complications of CD, it seems 
reasonable to put these patients on strict gluten-free diet and treat them with either 
corticosteroids or IVIG until clinical improvement.  
 
Conclusion 
The patient discussed in this case study presented with cerebellar syndrome and pyramidal 
tract involvement. The differential diagnosis of adult-onset cerebellar ataxia with normal 
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brain MRI findings is very wide and includes genetic, inflammatory, endocrinological, 
paraneoplastic and systemic illnesses. After thorough investigation, the diagnosis of ataxia 
due to CD was made based on duodenal biopsy and positive antibodies in both serum and 
CSF. Other causes were excluded by appropriate tests. 
Although there are many controversies about neurological manifestations of CD, this case 
demonstrated strong association between these two disorders. The findings of elevated protein 
content in the CSF with positive oligoclonal bands suggested an immune-mediated process, 
further supported by positive tTG and EMA in the CSF. 
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Video1. Down-beat nystagmus in all directions of gaze; more pronounced in full lateral gaze. 
